Curaleaf Holdings Crecimiento futuro

Future controles de criterios 0/6

Se prevé que los beneficios de Curaleaf Holdings disminuyan a un ritmo anual de 25.3%, mientras que sus ingresos anuales crecerán a un ritmo de 6.9% por año. Se espera que el BPA disminuya en un 7.9% al año.

Información clave

-25.3%

Tasa de crecimiento de los beneficios

-7.88%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Pharmaceuticals	14.4%
Tasa de crecimiento de los ingresos	6.9%
Rentabilidad financiera futura	n/a
Cobertura de analistas	Good
Última actualización	12 Jun 2026

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Actualización de narrativa • Jun 26

CURL.D: Share Repurchase Will Support Future Upside Despite Lower P/E Assumptions

Analysts have adjusted their price target on Curaleaf Holdings from $15.00 to about $12.50, citing updated fair value estimates that take into account revised profit margin assumptions and a lower projected future P/E multiple. What’s in the News for Curaleaf Holdings Curaleaf Holdings shareholders approved an amendment to the company’s articles at the June 22, 2026 annual general and special meeting, removing the automatic conversion feature of the Multiple Voting Shares following a potential listing of Subordinate Voting Shares on a major U.S. exchange.

Nueva narrativa • Jun 08

Rescheduling And International Expansion Will Reshape This Vertically Integrated Cannabis Operator

Catalysts About Curaleaf Holdings Curaleaf Holdings operates a vertically integrated cannabis business across U.S. and international medical and adult use markets. What are the underlying business or industry changes driving this perspective?

Previsiones de crecimiento de beneficios e ingresos

OTCPK:CURL.F - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2027	1,449	-165	109	156	6
12/31/2026	1,340	-81	39	142	7
3/31/2026	1,286	-113	55	120	N/A
12/31/2025	1,268	-247	73	138	N/A
9/30/2025	1,264	-268	69	144	N/A
6/30/2025	1,274	-257	50	136	N/A
3/31/2025	1,302	-243	63	158	N/A
12/31/2024	1,334	-228	66	164	N/A
9/30/2024	1,357	-206	37	127	N/A
6/30/2024	1,360	-221	54	134	N/A
3/31/2024	1,353	-237	46	111	N/A
12/31/2023	1,347	-230	5	75	N/A
9/30/2023	1,342	-346	-7	74	N/A
6/30/2023	1,334	-318	-35	71	N/A
3/31/2023	1,312	-268	-127	9	N/A
12/31/2022	1,275	-258	-88	46	N/A
9/30/2022	1,244	-157	-137	22	N/A
6/30/2022	1,234	-202	-150	11	N/A
3/31/2022	1,232	-223	-170	-7	N/A
12/31/2021	1,196	-206	-230	-58	N/A
9/30/2021	1,118	-164	-201	-27	N/A
6/30/2021	984	-90	-237	-89	N/A
3/31/2021	790	-57	-127	8	N/A
12/31/2020	627	-57	-114	12	N/A
9/30/2020	472	-52	-110	-25	N/A
6/30/2020	351	-50	-86	5	N/A
3/31/2020	282	-72	-110	-23	N/A
12/31/2019	221	-67	N/A	-38	N/A
9/30/2019	178	-57	N/A	-37	N/A
6/30/2019	137	-84	N/A	-50	N/A
3/31/2019	103	-64	N/A	-45	N/A
12/31/2018	77	-56	N/A	-33	N/A
9/30/2018	51	-40	N/A	-20	N/A
6/30/2018	36	-6	N/A	-10	N/A
3/31/2018	25	-3	N/A	-10	N/A
12/31/2017	19	-3	N/A	-8	N/A
12/31/2016	4	0	N/A	-2	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que CURL.F siga sin ser rentable en los próximos 3 años.

Beneficios vs. Mercado: Se prevé que CURL.F siga sin ser rentable en los próximos 3 años.

Beneficios de alto crecimiento: Se prevé que CURL.F siga sin ser rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (6.9% al año) de CURL.F crezcan más despacio que el mercado de US (12.7% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 6.9% al año) de CURL.F crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de CURL.F se prevé que sea elevada dentro de 3 años.

Descubre empresas en crecimiento

Análisis de la empresa y estado de los datos financieros

Datos	Última actualización (huso horario UTC)
Análisis de la empresa	2026/07/07 00:51
Precio de las acciones al final del día	2026/07/07 00:00
Beneficios	2026/03/31
Ingresos anuales	2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

Paquete	Datos	Marco temporal	Ejemplo Fuente EE.UU. ^*
Finanzas de la empresa	10 años	Cuenta de resultados Estado de tesorería Balance	Formulario SEC 10-K Formulario SEC 10-Q
Estimaciones del consenso de analistas	+3 años	Previsiones financieras Objetivos de precios de los analistas	Informes de análisis Blue Matrix
Precios de mercado	30 años	Precios de las acciones Dividendos, escisiones y acciones	Datos de mercado ICE Formulario S-1 de la SEC
Propiedad	10 años	Accionistas principales Información privilegiada	Formulario SEC 4 Formulario SEC 13D
Gestión	10 años	Equipo directivo Consejo de Administración	Formulario SEC 10-K Formulario SEC DEF 14A
Principales avances	10 años	Anuncios de empresas	Formulario SEC 8-K

^* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también contamos con guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Curaleaf Holdings, Inc. está cubierta por 13 analistas. 7 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

Analista	Institución
Aaron Grey	Alliance Global Partners
Frederico Yokota Choucair Gomes	ATB Cormark
Kenric Tyghe	Canaccord Genuity

Curaleaf Holdings Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Curaleaf Holdings, Inc. Provides Revenue Guidance for the First Quarter of 2025

Curaleaf Holdings, Inc. Provides Revenue Guidance for the Second Quarter of 2021

Recent updates

Curaleaf Holdings, Inc. to Report Q2, 2026 Results on Aug 05, 2026

CURL.D: Share Repurchase Will Support Future Upside Despite Lower P/E Assumptions

Curaleaf Holdings, Inc. Approves the Election of Faith Charles as Directors

Rescheduling And International Expansion Will Reshape This Vertically Integrated Cannabis Operator

Curaleaf Holdings, Inc., Annual General Meeting, Jun 22, 2026

Curaleaf Holdings, Inc. to Report Q1, 2026 Results on May 05, 2026

Select Unveils Select Briq 2 Vape

Curaleaf Holdings, Inc. announced that it has received $500 million in funding

Curaleaf Holdings, Inc. announced that it expects to receive $500 million in funding

Curaleaf Holdings, Inc. to Report Q4, 2025 Results on Feb 26, 2026

Curaleaf Holdings, Inc. Decides to Discontinue Its Hemp Division and Cease Operating in the State of Missouri

Curaleaf Holdings, Inc. to Report Q3, 2025 Results on Nov 05, 2025

Curaleaf Holdings, Inc. (TSX:CURA) acquired remaining 31.50% stake in Curaleaf International Holdings, Limited.

Curaleaf Holdings, Inc. to Report Q2, 2025 Results on Aug 06, 2025

Curaleaf Launches Anthem, a Classic Pre-Roll Brand Celebrating American Grown Cannabis

Curaleaf Holdings, Inc., Annual General Meeting, Jun 13, 2025

Curaleaf Holdings, Inc. Provides Revenue Guidance for the First Quarter of 2025

Curaleaf Holdings, Inc. Launches 'Reef' Flower Brand in Florida

Curaleaf Holdings, Inc. to Report Q4, 2024 Results on Mar 03, 2025

Curaleaf Holdings, Inc. (TSX:CURA) acquired Half Moon Nursery, Inc. and The assets of Dark Heart Nursery from Grace & Co., Inc. for approximately $2 million.

Curaleaf Holdings, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Curaleaf Holdings, Inc. to Report Q2, 2024 Results on Aug 07, 2024

Curaleaf Holdings, Inc. (TSX:CURA) completed the acquisition of Northern Green Canada Inc. (NGC).

Curaleaf Holdings, Inc., Annual General Meeting, Jun 14, 2024

Curaleaf Holdings, Inc. to Report Q1, 2024 Results on May 09, 2024

Curaleaf Holdings, Inc. (TSX:CURA) signed a deal to acquire Northern Green Canada Inc. (NGC).

Curaleaf Expands Zero Proof™ Brand Portfolio with Launch of Stir Fast-Acting THC Beverage Mix

Curaleaf Holdings, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Curaleaf Holdings, Inc. has completed a Follow-on Equity Offering in the amount of CAD 16.2 million.

Curaleaf Expands Brand Portfolio with Launch of Zero Proof ™ Cannabis-Infused Drinkables

Curaleaf Holdings, Inc., Annual General Meeting, Oct 04, 2023

Curaleaf Holdings, Inc.'s Select™ Brand Expands Product Offerings With Launch of Select Liquid Diamonds

Curaleaf Holdings, Inc. to Report Q2, 2023 Results on Aug 09, 2023

Curaleaf Holdings, Inc. Unveils Strategic National Rebrand of Select

Curaleaf Holdings, Inc. Announces Closure of Operations in California, Colorado and Oregon

Curaleaf Holdings, Inc. Announces Expansion of BlueKudu Infused Chocolate Flavors Available on Florida Retail Menus

Curaleaf Holdings, Inc. announced that it has received $475 million in funding

Curaleaf Holdings, Inc. Launches Select X Bites

Curaleaf Holdings, Inc. Announces the Release of Cliq by Select

Curaleaf Holdings, Inc. (CNSX:CURA) signed definitive documents to acquire Los Sueños Farms LLC for $75 million.

Curaleaf Holdings, Inc. Provides Revenue Guidance for the Second Quarter of 2021

PharmaCann Inc. acquired Elevate Takoma dispensary from Curaleaf Holdings, Inc. (CNSX:CURA).

Curaleaf Holdings, Inc. Completes Reorganization of its Maryland Business

Curaleaf Holdings, Inc. (CNSX:CURA) completed the acquisition of Maryland Compassionate Care and Wellness LLC.

Curaleaf Holdings, Inc. announced that it has received $130 million in funding

Curaleaf Holdings, Inc. Appoints Carlos Madrazo as Senior Vice President Investor Relations and Capital Markets

Curaleaf Holdings, Inc. (CNSX:CURA) signed a definitive agreement to acquire Emmac Life Sciences Limited for approximately £250 million.

Curaleaf Holdings, Inc. to Report Q4, 2020 Results on Mar 09, 2021

Curaleaf Holdings, Inc. has completed a Follow-on Equity Offering in the amount of CAD 275.55 million.

Curaleaf Holdings, Inc. announced that it has received CAD 50 million in funding

Curaleaf Holdings, Inc. Launches Fast Onset Nano Chews in Florida

Curaleaf Holdings, Inc. Announces Joseph Lusardi to Be Named Executive Vice-Chairman

Curaleaf Holdings, Inc. Announces Executive Changes

TerrAscend Corp. (CNSX:TER) signed a definitive agreement to acquire HMS Health, LLC and HMS Processing, LLC from Curaleaf Holdings, Inc. (CNSX:CURA) for $27.5 million.

Curaleaf Holdings, Inc. Announces Launch of Collection of Vape Cartridges

Curaleaf Holdings, Inc. Expands Product Line Featuring Fast Acting Nanoemulsion Technology with NANO Drops

Curaleaf Holdings, Inc. to Report Q3, 2020 Results on Nov 17, 2020

Curaleaf Holdings, Inc. (CNSX:CURA) acquired Verdure, Inc.

Curaleaf Holdings, Inc.'s Select Brand Announces Partnership with Jim Belushi and Belushi's Farm

Curaleaf Holdings, Inc. (CNSX:CURA) acquired 18% stake in Blackjack Collective from minority owners for $1.3 million.

Curaleaf Holdings, Inc. Launches Select Nano Gummies in California and its Line of Select Elite Live Cartridges in Nevada

Curaleaf Holdings, Inc. Appoints Talley Wettlaufer as Senior Vice President of Retail

Freehold Properties, Inc completed the acquisition of six properties located in Florida, Massachusetts and New Jersey from Curaleaf Holdings, Inc. (CNSX:CURA).

Curaleaf Holdings, Inc. (CNSX:CURA) completed the acquisition of three dispensaries of Arrow Alternative Care in Connecticut.

Curaleaf Holdings, Inc. announced that it has received CAD 27.500003 million in funding

Curaleaf Holdings, Inc. to Report Q2, 2020 Results on Aug 17, 2020